[SRNE] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
21-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -32.99%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 31,432 21,193 151,856 8,152 4,590 3,825 460 102.12%
PBT -359,576 -213,781 15,315 -64,833 -13,760 -36,359 -21,911 59.37%
Tax -473 -6,274 -36,038 -896 36,314 -1,702 10 -
NP -359,103 -203,540 9,061 -60,923 -45,811 -34,657 -21,911 59.34%
Tax Rate - - 235.31% - - - - -
Total Cost 390,535 224,733 142,795 69,075 50,401 38,482 22,371 61.02%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -1,142.48 -960.41 5.97 -747.34 -998.06 -906.07 -4,761.79 -21.16%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -2.56 -1.92 0.13 -1.21 -1.24 -1.30 -1.46 9.80%
EPS Diluted -2.56 -1.92 0.13 -1.21 -1.24 -1.30 -1.46 9.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.